FCS Leaders Spotlight Innovation and Collaboration at COA 2026 to Advance Community Oncology Care

Insights from FCS showcase forward-thinking solutions to expand access, enhance quality and strengthen patient-centered cancer care nationwide

Fort Myers, Fla., April 28, 2026 — Florida Cancer Specialists & Research Institute, LLC (FCS) senior leaders are highlighting innovative solutions developed across the statewide practice to help ensure cancer patients continue to receive high-quality care close to home. At the Community Oncology Alliance (COA) 2026 Community Oncology Conference this week, FCS leaders are joining industry stakeholders from across the country to tackle key clinical, operational, pharmacy and advocacy challenges impacting community oncology providers.

FCS Assistant Managing Physician David Wenk, MD, said, “At FCS, our focus has always been on anticipating the needs of our patients and providers and responding with thoughtful, forward-looking solutions. By continuously evolving how we deliver care, we’re strengthening the community oncology model and improving outcomes for the patients who depend on us.”

Serving as presenters for the 2026 Community Oncology Conference are:

• Ameet Patel, MD, MMHC, FCS director of cell therapy: “CAR T Comes to Main Street: Expanding Access, Empowering Care”
• Richard McDonough, MD, FCS director of advocacy & policy: “What I Wish I’d Known: First-Year Insights After Fellowship”, “Conference Opening Day Two: Update From the Co-Chairs” and “Conference Wrap-Up: Meeting Observations From the Co-Chairs”
• Jeanine Ewing, PharmD, BCOP, FCS clinical oncology pharmacist: “Communication in Action: Empowering Community Oncology Pharmacists to Optimize Prostate Cancer Care Across Urology & Oncology”
• Lucio N. Gordan, MD, FCS president & managing physician: “The Quality of Community Oncology: Presenting the COA Quality & Value Study”, “Oncology Innovation Showcase #1 – Chart Prep Tools” and “Oncology Innovation Showcase #2 – Agentic AI Solutions”
• Bradley Monk, MD, FACS, FACOG, FCS medical director of late-phase clinical research: “Expanding Clinical Trial Access in Community Oncology: Tech Tools & Support Strategies”

“As the future of oncology continues to evolve, FCS remains committed to working alongside leading providers nationwide to share best practices, advance innovation and reinforce a patient-centered approach to community-based cancer care,” said Ryan Ciarrocchi, FCS chief executive officer.

The Community Oncology Alliance is dedicated to ensuring that cancer patients have access to quality, affordable and accessible cancer care in their local communities.